[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356506-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356506-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","single-cell-based-identification-of-drug-synergy-with-immunotherapy-via-tumor-microenvironment-remodeling","Single-cell-based identification of drug synergy with immunotherapy via tumor microenvironment remodeling","","Identifying effective therapeutic drugs within the intricate tumor microenvironment (TME) remains challenging, especially given the absence of a systematic framework to analyze TME perturbations after treatment. A single-cell RNA sequencing repository for immunomodulatory drugs was created and L1000 unbiasedly screened 739 immune-modulating compounds across cancers. In mouse models, 12 TME remodeling meta-programs were defined, with antigen presentation, tissue repair, and salt stress enrichment, and responsive TMEs showed marked myeloid-derived suppressor cell depletion. An MP scoring algorithm quantified TME responsiveness and pinpointed allopurinol as a potent enhancer of anti-PD-1 therapy, producing tumor-free outcomes in vivo (4/6).",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/single-cell-based-identification-of-drug-synergy-with-immunotherapy-via-tumor-microenvironment-remodeling/356506/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/single-cell-based-identification-of-drug-synergy-with-immunotherapy-via-tumor-microenvironment-remodeling/356506.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is identifying effective drugs in the tumor microenvironment (TME) difficult?","Question",{"text":63,"@type":64},"Drug effectiveness is complicated by the TME’s complex and dynamic nature and by the lack of a robust framework to systematically analyze how the TME changes in response to therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What method and screening approach were used in the study?",{"text":68,"@type":64},"The study built a single-cell RNA sequencing repository of immunomodulatory drugs and used the L1000 platform for unbiased screening of 739 immune-modulating compounds across various cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the researchers determine drug synergy with immunotherapy?",{"text":72,"@type":64},"They identified 12 TME remodeling meta-programs in mouse models, developed an MP scoring algorithm to quantify TME responsiveness, and used it to nominate allopurinol as an enhancer of anti-PD-1 therapy with tumor-free outcomes in vivo (4/6).","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356506,1790171101,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Open access Original research  \nSingle-cell-based identification of drug synergy with immunotherapy via tumor microenvironment remodeling  \nZiruoyu Wang  ,1,2 Junchi Hu  ,1 Kailu Liu,1 Jie Xu,1 Jiao Li,1 Yihang Liu,1 Qinfeng Ma,1 Yu Dong,3 Yunmei Zhu,1 Kai Zhang,1 Dexin Wang,4 Xiaobo Wang,1 Shuai Wang,1 Jianbo Pan,1 Shuai Jiang,3 Jiaxue Wu,1 Wei Jiang  ,2  \nLing Zhang  ,5 Yongjun Dang  1,5  \nTo cite: Wang Z, Hu J, Liu K, et al. Single-cell-based identification of drug synergy with immunotherapy via tumor microenvironment remodeling. Journal for ImmunoTherapy of Cancer 2026;14:e014132 . doi:10.1136/jitc-2025-014132  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2025-014132](jitc-2025-014132)) .  \nAccepted 17 February 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nProfessor Yongjun Dang; [yjdang@cqmu.edu.cn](yjdang@cqmu.edu.cn)  \nProfessor Wei Jiang; [jiangw@fudan.edu.cn](jiangw@fudan.edu.cn)  \nDr Ling Zhang;  \nlingzhang02@hospital.cqmu. [edu.cn](edu.cn)  \nABSTRACT  \nBackground Identifying effective therapeutic drugs in the intricate tumor microenvironment (TME) is challenging, further complicated by the lack of a systematic framework for analyzing TME perturbations in response to therapeutic interventions.  \nMethods To address this, we established the single-cell RNA sequencing repository of immunomodulatory drugs resource and used the L1000 platform for unbiased screening of 739 immune-modulating compounds across various cancers.  \nResults Drug responses in mouse model revealed 12 distinct meta-programs associated with TME remodeling, enriched in biological processes such as antigen presentation, tissue repair, and salt stress response. Notably, myeloid-derived suppressor cells were markedly reduced in responsive TMEs compared with other cell types, underscoring their key immunosuppressive role. We developed an MP scoring algorithm to quantify  \nTME responsiveness, which successfully identified allopurinol—a gout medication—as a potent enhancer of anti-programmed cell death protein-1 therapy. This combination led to significant tumor-free outcomes (4/6) in vivo.  \nConclusions This work provides a robust framework for assessing TME remodeling that uncovers genes and compounds that significantly modulate immunotherapeutic efficacy.  \nBACKGROUND  \nIn the complex and dynamic tumor microenvironment (TME), identifying effective therapeutic drugs remains a significant challenge. This difficulty is further compounded by the lack of a robust framework for systematically analyzing the TME and its interactions with immunotherapy. Cancer biology and therapy have been significantly advanced by our growing understanding of the immunoregulatory mechanisms in TME.1 Importantly, the functionality of immune cells within the TMEis fundamentally influenced by tumor cells themselves. Across many solid tumor types, intratumor heterogeneity (ITH) is a prevalent  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Therapeutic responses are strongly influenced by the tumor microenvironment (TME) . However, no systematic framework exists to quantify druginduced TME remodeling across cancers, limiting the rational design of effective immunotherapy combinations.\u003Cbr>WHAT THIS STUDY ADDS |\n| --- |\n| ⇒ We built the single-cell RNA sequencing repository of immunomodulatory drugs resource and, via unbiased screening of 739 compounds, defined 12 TME meta-programs (MPs) and an MP scoring algorithm that highlight myeloid-derived suppressor cell depletion as a hallmark of response and nominate allopurinol as a potent anti-programmed cell death protein-1 adjunct yielding tumor-free cures in vivo.\u003Cbr>HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY","cbCaisdflSM3kYwh","https://ap.wps.com/l/cbCaisdflSM3kYwh","pdf",8908670,15,"English","# Abstract\n# Background\n# What Is Already Known on This Topic\n# What This Study Adds\n# How This Study Might Affect Research, Practice or Policy","[{\"question\":\"Why is identifying effective drugs in the tumor microenvironment (TME) difficult?\",\"answer\":\"Drug effectiveness is complicated by the TME’s complex and dynamic nature and by the lack of a robust framework to systematically analyze how the TME changes in response to therapy.\"},{\"question\":\"What method and screening approach were used in the study?\",\"answer\":\"The study built a single-cell RNA sequencing repository of immunomodulatory drugs and used the L1000 platform for unbiased screening of 739 immune-modulating compounds across various cancers.\"},{\"question\":\"How did the researchers determine drug synergy with immunotherapy?\",\"answer\":\"They identified 12 TME remodeling meta-programs in mouse models, developed an MP scoring algorithm to quantify TME responsiveness, and used it to nominate allopurinol as an enhancer of anti-PD-1 therapy with tumor-free outcomes in vivo (4/6).\"}]","Single-cell-based identification of drug synergy with immunotherapy via tumor microenvironment remodeling | PDF",1790125700,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6380f0a42c9757d75ea3ce57fda2bc2.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85e6f29653b0ef21d2a72e60b9cb8500.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71267dce9037bc988c71788dc2ae19f6.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1126152e044d7707adf454a4d27a50b5.webp",980,1306]